Dianthus Therapeutics (DNTH) Asset Utilization Ratio (2022 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly Asset Utilization Ratio of 0.01 in Q3 2025, down 52.44% quarter-over-quarter from 0.01 in Q2 2025, and down 53.26% on a YoY basis from 0.01 in Q3 2024.
Dianthus Therapeutics (DNTH) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.01 for Q3 2025.
- In Q3 2025, Asset Utilization Ratio fell 53.26% year-over-year to 0.01; the TTM figure through Sep 2025 stood at 0.01 (down 53.26% YoY), while the FY2024 annual figure was 0.02, up 4.66% from the prior year.
- Asset Utilization Ratio was 0.01 for Q3 2025 at Dianthus Therapeutics, down from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.05 in Q2 2023 to a low of 0.01 in Q3 2025.
- Historically, Asset Utilization Ratio has averaged 0.02 across 4 years, with a median of 0.02 in 2023.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio surged 277.01% in 2023, then sank 76.98% in 2024.
- A 4-year view of Asset Utilization Ratio shows it stood at 0.02 in 2022, then fell by 20.08% to 0.02 in 2023, then increased by 13.62% to 0.02 in 2024, then plunged by 59.73% to 0.01 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.01 (Q3 2025), 0.01 (Q2 2025), and 0.02 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.01 |